FY2024 Earnings Estimate for CRSP Issued By Leerink Partnrs
Leerink Partnrs boosted their FY2024 earnings per share (EPS) estimates for CRISPR Therapeutics in a note issued to investors ...
The dodo bird is extinct. This scientist says she can bring it back.
Inside, between rows of incubators and microscopes, Beth Shapiro and her team are attempting a feat straight out of science ...
CRISPR Therapeutics AG (NASDAQ:CRSP) Receives $78.38 Average Price Target from Analysts
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has earned a consensus recommendation of “Hold” from the nineteen ...